http://www.fda.gov/cder/orange/appendix_a.txt 4, ACETAMINOPHEN PHENAPHEN-650 W/ CODEINE, ACETAMINOPHEN PHENAZINE, PHENDIMETRAZINE TARTRATE PHENAZINE-35, PHENDIMETRAZINE TARTRATE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENERGAN FORTIS, PROMETHAZINE HYDROCHLORIDE PHENERGAN PLAIN, PROMETHAZINE HYDROCHLORIDE PHENERGAN VC W/ CODEINE, CODEINE PHOSPHATE PHENERGAN VC, PHENYLEPHRINE HYDROCHLORIDE PHENERGAN W/ CODEINE, CODEINE...
Prescription and Over-the-Counter Drug Product List: 6/2003 >D> AP + WYETH AYERST 5,000 UNITS/VIAL N17055 001 JUN DISC >A> @ 5,000 UNITS/VIAL N17055 001 JUN DISC >D> AP + 10,000 UNITS/VIAL N17055 002 JUN DISC >A> @ 10,000 UNITS/VIAL N17055 002 JUN DISC GUANABENZ ACETATE TABLET; ORAL GUANABENZ ACETATE >D> AB WATSON LABS EQ 8MG BASE N74025 002 FEB 28, 1994 JUN CRLD >A> AB + EQ 8MG BASE N74025 002 FEB 28, 1994 JUN CRLD >D> WYTENSIN >D> AB WYETH...
author: AUTHOR
Prescription and Over-the-Counter Drug Product List: 3/2003 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL FIORICET W/ CODEINE -D- AB + NOVARTIS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN -A- AB + WATSON PHARMS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL CODRIX -A- + ANDRX PHARMS 500MG;30MG N40441 001...
author: AUTHOR
FDA Drug Approvals List August 2001 JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE Active Ingredient(s): COPPER OTC/RX Status: RX Application #:018612 Labeling Supplement#: 026 To Original New Drug Application Approval Date: 24-AUG-01 Trade Name: NICORETTE Dosage Form: GUM, CHEWING Applicant: SMITHKLINE BEECHAM CONSUMER HEALTHCARE LP Active Ingredient(s): NICOTINE POLACRILEX OTC/RX Status: RX Application #: 014879 Labeling...
Prescription and OTC Drug Product List October 1997 Prescription and Over-the-Counter Drug Product List - 17th Edition Cumulative Supplement Number 10: Jan '97 - Oct '97 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE CAPSULE; ORAL OXYCODONE AND...
Prescription and OTC Drug Product List 6/1998 Prescription and Over-the-Counter Drug Product List - 18th Edition Cumulative Supplement Number 6: June 1998 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST - ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE CAPTOPRIL; HYDROCHLOROTHIAZIDE TABLET; ORAL TABLET; ORAL OXYCODONE AND ACETAMINOPHEN CAPOZIDE 25/15 - ADD - AA DURAMED 325MG;5MG N40272 001 - ADD - AB BRISTOL...
FDA Drug Approvals List- June 1998 Drug Approvals for June 1998 Definitions and Notes June 1998 Original New Drug Applications Original Application #: 020865 Approval Date: 29-JUN-98 Trade Name: MAXALT - MLTRA ISC Chemical Type: 3 Therapeutic Potential: S Dosage Form: TABLET Applicant: MERCK RESEARCH LABORATORIES DIV MERCK AND CO INC Active Ingredient(s): RIZATRIPTAN BENZOATE OTC/RX Status: RX Indication(s): Acute...
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Quinidine, Serum Quinidine, Serum ---- Number 007831 CPT 80194 Synonyms Cardioquin®; Duraquin®; Quinaglute®; Quinidex ®; Quinora® Specimen Serum or plasma Volume 1 mL Minimum Volume 0.3 mL Container Red-stopper tube or green-stopper (heparinized plasma) tube.
Antiarrhythmic medications for fast heart rates - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Antiarrhythmic medications for fast heart rates - [Medication] - Quest Diagnostics Patient Health Library Antiarrhythmic medications for fast heart rates - [Medication] - Quest Diagnostics Patient Health Library Amiodarone, antiarrhythmic medications,...
Antiarrhythmic medications for atrial fibrillation - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Antiarrhythmic medications for atrial fibrillation - [Medication] - Quest Diagnostics Patient Health Library Antiarrhythmic medications for atrial fibrillation - [Medication] - Quest Diagnostics Patient Health Library Heart and circulation, Heart problems,...
http://www.fda.gov/cder/ogd/rld/RLD_LABELING_APPROVED_JUN_1998.HTML Reference Listed Drug Labeling Approved in June 1998 Some of the product names below contain links to the approved labeling or the supplemental approval letter describing the specific changes.- Click on the product name to view the approved labeling changes in Adobe Acrobat format
http://www.fda.gov/cder/foi/label/2001/20779s32lbl.pdf AGOURON PHARMACEUTICALS, INC
http://www.fda.gov/cder/foi/label/2001/20779s32lbl.pdf page 21
V:\DAVDP\CSO\BELOUIN\IndigoNda s\NDA\20659-20945\LETTERS\SLR025&005APPROVALLETTER.doc page 30
author: Sean Belouin
H:\PM Folder\NDA ltrs\12796s49ap.doc page 1
author: Quynh Nguyen
4:00 page 10
author: Christine Wildman
09001464801f168b.pdf page 29
author: gracej
duplicates:http://www.fda.gov/cder/foi/label/2002/20659S27lbl.pdf
20-779 S-038 AP VIRACEPT.pdf AGOURON PHARMACEUTICALS, INC
author: gracej
20-779 S-038 AP VIRACEPT.pdf page 23
author: gracej
http://www.fda.gov/cder/foi/appletter/2001/12796s49ltr.pdf page 1
CA4 outline v2 INNOVATIONS IN CARDIOVASCULAR DRUGS IV, 1997Ð 2001 Final Outline Chapter 1: Executive Summary The Traditional Cardiovascular Market Innovative Cardiovasculars Competitive Strategies Chapter 2: Introduction Scope of the Revised Study Expanded Coverage of Innovative Cardiovascular Drug ...
author: Dan
NUMERICAL INDEX NUMERICAL INDEX 000455 see Thyroid Panel 000620 see Thyroid Panel With TSH 000679 see Hemoglobinopathy Profile 000703 see Renin Activity and Aldosterone 000810 see Vitamin B12 and Folates 001016 see Calcium, Serum 001024 see Phosphorus, Serum 001032 see Glucose, Serum 001040 see Urea Nitrogen, Serum 001057 see Uric Acid, Serum 001065 see Cholesterol, Total 001073 see Protein, Total,...
Esoterix, Inc. -- Test Menu vivax) 300523 Platelet Antibody, Direct 300521 Platelet Antibody Drug-Induced *** 300520 Platelet Antibody Screen, Indirect (HLA, Platelet Glycoprotein) 500679 Platelet Count 300504 Platelet Factor 4 300805 Platelet Neutralization Procedure 300524 Platelet Specific Antibody (GP IIb/IIIa) 300526 Platelet Specific Antigen PLA1 (HPA-1a) 300531 Platelet Specific Antigen-2 (PLA2)...
author: Esoterix, Inc.
